January 8th 2025
The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.
January 7th 2025
The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.
January 6th 2025
Sanofi and SK bioscience expand collaboration on pneumococcal conjugate vaccines, including a 21-valent candidate for pediatric populations.
December 18th 2024
Your daily dose of the clinical news you may have missed.
December 10th 2024
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
The Case of an Itchy Scalp and Forehead Rash
Urticarial wet plaque, smaller pink urticarial lesions on the temple and eyelid, eyelid edema, no vesicles or pain. What's your diagnosis?
Shingrix and Zostavax: A Compare and Contrast Quiz
Take our 5-question quiz to see what you know about these 2 vaccines, the similarities and differences, and how to accommodate both, for now.
Hepatitis C Infection Rates Relate to Opioid Epidemic
A new study finds cases of acute HCV infection increasing on pace with the rise in numbers of opioid abusers who inject drugs.
5-Question Quiz on HCV
It's a short quiz but it covers a broad range of knowledge about testing, treatment, and drug choices in persons with HCV infection.
Hepatitis C: Toward New Public Health Models to Improve Detection and Treatment
A community health model based on direct treatment via primary care epxanded detection and treatment of HCV and also increased life expectancy.
Sofosbuvir Regimens Benefit Hard to Treat Patients with Both HIV and Hepatitis C
Favorable results seen with sofosbuvir-containing regimens in these complex patients need to be tempered with the high potential for adverse drug interactions.
HCV Quiz: A Quick Numbers Game
In this short quiz, we challenge you to choose 4 correct figures and 1 correct fact from your vast store of knowledge on HCV infection.
Sofosbuvir/ribavirin vs HCV Genotype 2: Clinical Success Story
Read a concise review of a new real-world study that shows high efficacy for this all-oral combination against HCV GT2.
Top 3 Hep C Studies for Primary Care
Highlights of 3 studies from 2017 that support the role of PCPs in HCV infection treatment, including prescribing direct-acting antiviral agents.
Second Generation Direct-Antivirals for HCV in the Real World
Clinical trials of second generation direct-acting antivirals in HCV show high cure rates. But do those rates reflect real life?
HCV and Primary Care: A Special Report Recap
For PCPs, now poised to play a bigger role in screening and care for patients with HCV, we highlight 10 forces reshaping the HCV landscape.
Quiz: An Immunization Mixed Bag
Flu, shingles, HPV-test a bit of your knowledge on a range of vaccine-preventable diseases.
HCV Screening in Special Populations
Injection drug users, pregnant women, men who have sex with men – who needs to be screened for HCV? Click here for the latest recommendations.
Quiz: Surprising Facts About Hepatitis C
Are you up-to-date on HCV? Take this quick quiz and find out.
11 New Medications for Primary Care
Here: a quick look at newly approved agents for primary care that will soon be coming your way.
Quiz on Hepatitis C: By the Numbers
World War I, genotype 3, 25% to 30%, 7 to 9 weeks-see what you know about the numbers related to HCV infection.
Quiz: Shingles Vaccination Past, Present, Future
A new shingles vaccine could make Zostavax an immunization of the past. Take our short quiz on herpes zoster and shingles prevention.
Hepatitis C: ABCs for Patients
Here, in plain language, a list of the most common questions you may hear about HCV and the answers, in brief.
HCV Screening: Focus on Special Populations
Every patient encounter is an opportunity to screen for hepatitis C. Certain women of childbearing age must be included as an at-risk population.
Postmarket Drug Safety Quiz: 8 Questions About Risk
Test your knowledge of the safety events that have occurred involving FDA-approved drugs since the turn of the century.
Does DAA Therapy Up Risk for Liver Cancer? It's Debatable
Eight studies at the 2017 International Liver Congress illuminate the question but the answer is open to interpretation.
Post-Test on Hepatitis C in Primary Care
Take this brief quiz to see what you’ve learned about the challenges and opportunities of HCV management.
Hepatitis C Drugs Meet Resistance Issues
Resistance-associated variants limit the activity of some drugs, but HIV infection treatment may offer some guidance.
Newer Hepatitis C Drugs Mean Direct Action
The “modern era” of treatment features multiple DAAs that target specific steps within the HCV life cycle.
Medicaid Is Tight on Hepatitis C Drug Coverage
State Medicaid programs and private insurance companies have balked at providing these drugs to their insured customers. But the tide is turning.
Hepatitis C Report: What Tests to Order
Testing is recommended for the persons who are more likely to have the virus but not know it.
Hep C Case Challenges for Primary Care
Test your knowledge of screening and HCV management with these three short case quizzes.
Hepatitis C: Pre-treatment Testing and Monitoring At-a-Glance
What are the most important labs to monitor before, during, and after HCV treatment? Essentials in this brief slide show.
Hepatitis C Screening for High Risk Patients
Patients can be identified at earlier stages of disease, before serious liver damage, and have improved clinical outcomes.
Hepatitis C Report: Tuning in to a Silent Epidemic
Knowing the origin and causes could help clinicians better determine who to screen and treat.